Ashburton (Jersey)’s Pfizer PFE Stock Holding History

Ashburton (Jersey)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,070	Closed	-$39K	–	60
2021 Q1	$39K	Sell	1,070 -4,236	-80%	-$150K	0.02%	39
2020 Q4	$195K	Sell	5,306 -287	-5%	-$10.5K	0.09%	29
2020 Q3	$174K	Hold	5,593	–	–	0.09%	28
2020 Q2	$174K	Buy	+5,593	New	+$190K	0.09%	28
2019 Q4	–	Sell	-5,396	Closed	-$184K	–	105
2019 Q3	$184K	Buy	+5,396	New	+$196K	0.09%	31
2019 Q2	–	Sell	-57,142	Closed	-$2.3M	–	112
2019 Q1	$2.3M	Buy	57,142 +1,033	+2%	+$41.4K	1.17%	13
2018 Q4	$2.32M	Hold	56,109	–	–	1.09%	14
2018 Q3	$2.35M	Sell	56,109 -1,644	-3%	-$63.3K	0.9%	14
2018 Q2	$1.99M	Buy	57,753 +458	+0.8%	+$15.7K	0.86%	14
2018 Q1	$1.93M	Buy	57,295 +3,710	+7%	+$128K	0.8%	15
2017 Q4	$1.84M	Buy	53,585 +16,326	+44%	+$557K	0.73%	27
2017 Q3	$1.26M	Buy	37,259 +3,794	+11%	+$122K	0.55%	33
2017 Q2	$1.07M	Sell	33,465 -26,062	-44%	-$822K	0.61%	22
2017 Q1	$1.93M	Hold	59,527	–	–	0.92%	23
2016 Q4	$1.83M	Buy	59,527 +5,818	+11%	+$178K	0.79%	31
2016 Q3	$1.73M	Buy	+53,709	New	+$1.8M	0.79%	29

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ashburton (Jersey)'s PFE Position: Q2 2021 in Review

Ashburton (Jersey) sold out of Pfizer (PFE) in Q2 2021, closing a stake of 1,070 shares — an estimated $39K sold.

Ashburton (Jersey) first reported a position in PFE in Q3 2016 and held it in 16 quarters. The position peaked at $2.35M in Q3 2018. 2,734 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Ashburton (Jersey) reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Ashburton (Jersey) sold 1,070 Pfizer shares in Q2 2021, an estimated $39K.
Ashburton (Jersey) first reported a position in Pfizer in Q3 2016 and held it in 16 quarters.
Ashburton (Jersey)'s Pfizer position peaked at $2.35M in Q3 2018.
2,734 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Ashburton (Jersey)'s 13F filing for Q2 2021, filed 26 May 2023.